SPY401.99+0.27 0.07%
DIA323.97+1.74 0.54%
IXIC11,736.92-68.09 -0.58%

BRIEF-Shenzhen Hepalink Pharmaceutical Posts QTRLY Net Profit Attributable Of RMB234.9 Million

reuters.com · 04/29/2022 07:26
BRIEF-Shenzhen Hepalink Pharmaceutical Posts QTRLY Net Profit Attributable Of RMB234.9 Million

- Shenzhen Hepalink Pharmaceutical Group Co Ltd SHEZF:

  • QTRLY NET PROFIT ATTRIBUTABLE RMB234.9 MILLION VERSUS RMB143.5 MILLION

  • QTRLY OPERATING REVENUE RMB1.91 BILLION VERSUS RMB1.27 BILLION

Source text for Eikon: nHKS1wBmBk

Further company coverage: SHEZF


((Reuters.Briefs@thomsonreuters.com;))